These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22449447)

  • 41. Altered lacunar and vascular porosity in osteogenesis imperfecta mouse bone as revealed by synchrotron tomography contributes to bone fragility.
    Carriero A; Doube M; Vogt M; Busse B; Zustin J; Levchuk A; Schneider P; Müller R; Shefelbine SJ
    Bone; 2014 Apr; 61():116-24. PubMed ID: 24373921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oesophageal morphometry and residual strain in a mouse model of osteogenesis imperfecta.
    Gregersen H; Weis SM; McCulloch AD
    Neurogastroenterol Motil; 2001 Oct; 13(5):457-64. PubMed ID: 11696107
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dietary fluoride restriction does not alter femoral biomechanical strength in col1a2-deficient (oim) mice with type I collagen glomerulopathy.
    Carleton SM; Whitford GM; Phillips CL
    J Nutr; 2010 Oct; 140(10):1752-6. PubMed ID: 20724489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Skeletal muscle weakness in osteogenesis imperfecta mice.
    Gentry BA; Ferreira JA; McCambridge AJ; Brown M; Phillips CL
    Matrix Biol; 2010 Sep; 29(7):638-44. PubMed ID: 20619344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta.
    Lindahl K; Barnes AM; Fratzl-Zelman N; Whyte MP; Hefferan TE; Makareeva E; Brusel M; Yaszemski MJ; Rubin CJ; Kindmark A; Roschger P; Klaushofer K; McAlister WH; Mumm S; Leikin S; Kessler E; Boskey AL; Ljunggren O; Marini JC
    Hum Mutat; 2011 Jun; 32(6):598-609. PubMed ID: 21344539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two bovine models of osteogenesis imperfecta exhibit decreased apatite crystal size.
    Fisher LW; Eanes ED; Denholm LJ; Heywood BR; Termine JD
    Calcif Tissue Int; 1987 May; 40(5):282-5. PubMed ID: 3107782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-Lethal Type VIII Osteogenesis Imperfecta Has Elevated Bone Matrix Mineralization.
    Fratzl-Zelman N; Barnes AM; Weis M; Carter E; Hefferan TE; Perino G; Chang W; Smith PA; Roschger P; Klaushofer K; Glorieux FH; Eyre DR; Raggio C; Rauch F; Marini JC
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3516-25. PubMed ID: 27383115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strontium Ranelate Reduces the Fracture Incidence in a Growing Mouse Model of Osteogenesis Imperfecta.
    Shi C; Hu B; Guo L; Cao P; Tian Y; Ma J; Chen Y; Wu H; Hu J; Deng L; Zhang Y; Yuan W
    J Bone Miner Res; 2016 May; 31(5):1003-14. PubMed ID: 26679066
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cortical bone properties in the Brtl/+ mouse model of Osteogenesis imperfecta as evidenced by acoustic transmission microscopy.
    Blouin S; Fratzl-Zelman N; Roschger A; Cabral WA; Klaushofer K; Marini JC; Fratzl P; Roschger P
    J Mech Behav Biomed Mater; 2019 Feb; 90():125-132. PubMed ID: 30366302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced diaphyseal strength associated with high intracortical vascular porosity within long bones of children with osteogenesis imperfecta.
    Albert C; Jameson J; Smith P; Harris G
    Bone; 2014 Sep; 66():121-30. PubMed ID: 24928496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electron Microscopy Reveals Structural and Chemical Changes at the Nanometer Scale in the
    Kłosowski MM; Carzaniga R; Abellan P; Ramasse Q; McComb DW; Porter AE; Shefelbine SJ
    ACS Biomater Sci Eng; 2017 Nov; 3(11):2788-2797. PubMed ID: 33418703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta.
    Berman AG; Wallace JM; Bart ZR; Allen MR
    Matrix Biol; 2016; 52-54():19-28. PubMed ID: 26707242
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone mass and mineralization in osteogenesis imperfecta.
    Fratzl-Zelman N; Misof BM; Klaushofer K; Roschger P
    Wien Med Wochenschr; 2015 Jul; 165(13-14):271-7. PubMed ID: 26208477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Collagen (I) homotrimer potentiates the osteogenesis imperfecta (oim) mutant allele and reduces survival in male mice.
    Lee KJ; Rambault L; Bou-Gharios G; Clegg PD; Akhtar R; Czanner G; van 't Hof R; Canty-Laird EG
    Dis Model Mech; 2022 Sep; 15(9):. PubMed ID: 36106514
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myocardial mechanics and collagen structure in the osteogenesis imperfecta murine (oim).
    Weis SM; Emery JL; Becker KD; McBride DJ; Omens JH; McCulloch AD
    Circ Res; 2000 Oct; 87(8):663-9. PubMed ID: 11029401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse.
    Kalajzic I; Terzic J; Rumboldt Z; Mack K; Naprta A; Ledgard F; Gronowicz G; Clark SH; Rowe DW
    Endocrinology; 2002 May; 143(5):1594-601. PubMed ID: 11956140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment.
    Sinder BP; Salemi JD; Ominsky MS; Caird MS; Marini JC; Kozloff KM
    Bone; 2015 Feb; 71():115-23. PubMed ID: 25445450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta.
    Weber M; Roschger P; Fratzl-Zelman N; Schöberl T; Rauch F; Glorieux FH; Fratzl P; Klaushofer K
    Bone; 2006 Sep; 39(3):616-22. PubMed ID: 16644299
    [TBL] [Abstract][Full Text] [Related]  

  • 59. OIM and related animal models of osteogenesis imperfecta.
    Shapiro JR; Mcbride DJ; Fedarko NS
    Connect Tissue Res; 1995; 31(4):265-8. PubMed ID: 15612365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of rapamycin on bone mass and strength in the α2(I)-G610C mouse model of osteogenesis imperfecta.
    Bateman JF; Sampurno L; Maurizi A; Lamandé SR; Sims NA; Cheng TL; Schindeler A; Little DG
    J Cell Mol Med; 2019 Mar; 23(3):1735-1745. PubMed ID: 30597759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.